22157.jpg
Global Opioid Analgesics Market Review 2016-2020 and Forecast 2021-2031 | Increasing Prevalence of Chronic Disease & Surgical Procedures and Neuropathic & Chronic Pain
15 déc. 2021 05h03 HE | Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "Opioid Analgesics Market Forecast, Trend Analysis & Opportunity Assessment 2021-2031" report has been added to ResearchAndMarkets.com's offering....
California Behavioral Health Logo.png
Fentanyl in Counterfeit Adderall: California Behavioral Health Has the Lowdown on this Worrying Discovery
12 oct. 2021 09h00 HE | California Behavioral Health
Cathedral City, CA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- California Behavioral Health has expressed concerns about a recent case of fentanyl being found in counterfeit Adderall purchased online. ...
22157.jpg
Worldwide Industry for Pain Management Drugs to 2027 - Advancements in Drug Development Presents Opportunities
08 oct. 2020 05h09 HE | Research and Markets
Dublin, Oct. 08, 2020 (GLOBE NEWSWIRE) -- The "Pain Management Drugs Market by Drug Class and Indication: Global Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to...
22157.jpg
Global Opioid Drugs Markets 2019-2020 & Forecast to 2028: Increased Number of Lawsuits Against the Manufacturers of Opioid Drugs Restraining Growth
29 sept. 2020 06h24 HE | Research and Markets
Dublin, Sept. 29, 2020 (GLOBE NEWSWIRE) -- The "Global Opioid Drugs Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global opioids drug market to proliferate with...
psychemdicslogo.jpg
Psychemedics Corporation Announces 4th Quarter and Year-End Results
11 févr. 2020 17h25 HE | Psychemedics Corporation
ACTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019.  The...
psychemdicslogo.jpg
Psychemedics Announces Second Quarter Results and Declares 92nd Consecutive Quarterly Dividend
23 juil. 2019 17h25 HE | Psychemedics Corporation
ACTON, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2019.  The Company also announced...
Prescription Drug Monitoring Programs Don’t Work, according to Article in the Journal of American Physicians and Surgeons
13 juin 2019 12h25 HE | Association of American Physicians and Surgeons
TUCSON, Ariz., June 13, 2019 (GLOBE NEWSWIRE) -- In response to the rising rate of drug overdose deaths, 49 states had a Prescription Drug Monitoring Program (PDMP) by 2014. By requiring physicians...
psychemdicslogo.jpg
Psychemedics Test for Fentanyl Detection Cleared by FDA
24 avr. 2019 08h00 HE | Psychemedics Corporation
ACTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the industry’s...
IonSense and Cayman Chemical Collaboration Reaches 1000 Compound Milestone in Development of MS Library of Drugs of Abuse
04 oct. 2018 10h06 HE | IonSense
SAUGUS, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- IonSense, Inc. has announced that in collaboration with Cayman Chemical, Inc. they have built and validated a mass spectral database of 1000...
West Virginia Escalates War on Pain Control, States the Association of American Physicians and Surgeons (AAPS)
11 juil. 2018 13h56 HE | Association of American Physicians and Surgeons
TUCSON, Ariz., July 11, 2018 (GLOBE NEWSWIRE) -- In its zeal to combat the epidemic of deaths from opioid overdose, West Virginia has enacted another impediment for physicians who use these drugs...